Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial
Open Access
- 11 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (10) , 1198-1206
Abstract
Aims To examine the relationship between revascularization within 7 days and 1-year mortality among ST-elevation myocardial infarction patients enrolled in GUSTO-V trial (n=13 451). To examine the relative contribution of system and patient level factors to the variation in international revascularization rates, and their impact on mortality outcomes. Methods and results Patients from North America (USA, Canada), Australia, and Europe (UK, France, Germany, Italy, Spain, Poland, Norway, The Netherlands, Belgium, Finland) were included in the study. Revascularization was associated with lower 1-year mortality. Norway, Belgium, Spain, Poland, and Italy also had lower than expected revascularization rates but higher than expected mortality rates. France and USA had almost two times the expected rate of 7-day revascularization, which was associated with modest mortality benefits. Patients' propensity for revascularization based on clinical factors alone was associated with lower 1-year mortality (OR 0.97, 95% CI: 0.96–0.99). Country-level factors had an impact on propensity for revascularization but no impact on 1-year mortality. Conclusion Our study reveals the potential for some countries with lower than expected 7-day revascularization rates to improve their clinical outcomes. Also highlighted is the possibility for more economically efficient delivery of care in USA and France.Keywords
This publication has 22 references indexed in Scilit:
- Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 2005
- Immediate angioplasty after thrombolysis: a systematic reviewCanadian Medical Association Journal, 2005
- Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study)JACC, 2005
- Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and CanadaCirculation, 2004
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation, 2004
- Population need for coronary revascularisation: are national targets for England credible?Heart, 2002
- Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-IIEuropean Heart Journal, 2001
- Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trialThe Lancet, 2001
- Use of Medical Resources and Quality of Life after Acute Myocardial Infarction in Canada and the United StatesNew England Journal of Medicine, 1994
- Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: Variation by country beyond predictive profileJACC, 1993